Detalhe da pesquisa
1.
A retrospective study of cladribine and low-dose cytarabine-based regimens for the treatment of chronic myelomonocytic leukemia and secondary acute myeloid leukemia.
Cancer
; 129(4): 560-568, 2023 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36458426
2.
Performance of IPSS-M in patients with myelodysplastic syndrome after hypomethylating agent failure.
Am J Hematol
; 98(10): E281-E284, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37515433
3.
The outcomes of patients with chronic myeloid leukemia treated with third-line BCR::ABL1 tyrosine kinase inhibitors.
Am J Hematol
; 98(4): 658-665, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36683287
4.
Evolving trends and outcomes in older patients with acute myeloid leukemia including allogeneic stem cell transplantation.
Am J Hematol
; 98(9): 1383-1393, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37334870
5.
Isavuconazole as Primary Antifungal Prophylaxis in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome: An Open-label, Prospective, Phase 2 Study.
Clin Infect Dis
; 72(10): 1755-1763, 2021 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32236406
6.
A phase 1b/2 study of azacitidine with PD-L1 antibody avelumab in relapsed/refractory acute myeloid leukemia.
Cancer
; 127(20): 3761-3771, 2021 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34171128
7.
Phase II study of azacitidine with pembrolizumab in patients with intermediate-1 or higher-risk myelodysplastic syndrome.
Br J Haematol
; 195(3): 378-387, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34340254
8.
Venetoclax with decitabine vs intensive chemotherapy in acute myeloid leukemia: A propensity score matched analysis stratified by risk of treatment-related mortality.
Am J Hematol
; 96(3): 282-291, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33264443
9.
High-grade B-cell lymphomas with TdT expression: a diagnostic and classification dilemma.
Mod Pathol
; 32(1): 48-58, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30181564
10.
Sotatercept for anemia of myelofibrosis: a phase II investigator-initiated study.
Haematologica
; 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38572554
11.
Ruxolitinib therapy is associated with improved renal function in patients with primary myelofibrosis.
Ann Hematol
; 98(7): 1611-1616, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31093708
12.
Results of second salvage therapy in 673 adults with acute myelogenous leukemia treated at a single institution since 2000.
Cancer
; 124(12): 2534-2540, 2018 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29645075
13.
Novel hematological parameters for the evaluation of patients with myeloproliferative neoplasms: the immature platelet and reticulocyte fractions.
Ann Hematol
; 96(5): 733-738, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28247057
14.
Clinical outcomes in adult patients with aplastic anemia: A single institution experience.
Am J Hematol
; 92(12): 1295-1302, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28850699
15.
Conditional survival in patients with chronic myeloid leukemia in chronic phase in the era of tyrosine kinase inhibitors.
Cancer
; 122(2): 238-48, 2016 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26479889
16.
Malignancy-associated hemophagocytic lymphohistiocytosis in adults: Relation to hemophagocytosis, characteristics, and outcomes.
Cancer
; 122(18): 2857-66, 2016 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27244347
17.
Outcomes of relapsed or refractory acute myeloid leukemia after frontline hypomethylating agent and venetoclax regimens.
Haematologica
; 106(3): 894-898, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32499238
18.
RUNX3 promoter hypermethylation is frequent in leukaemia cell lines and associated with acute myeloid leukaemia inv(16) subtype.
Br J Haematol
; 169(3): 344-51, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25612675
19.
Mutational landscape of myelodysplastic/myeloproliferative neoplasm-unclassifiable.
Blood
; 132(19): 2100-2103, 2018 11 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30242087
20.
Intensive chemotherapy is more effective than hypomethylating agents for the treatment of younger patients with myelodysplastic syndrome and elevated bone marrow blasts.
Am J Hematol
; 94(7): E188-E190, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30977182